Tag Archives: FDA

5 Things You'll Want to Know From the World's Biggest Marijuana Biotech

5 Things You’ll Want to Know From the World’s Biggest Marijuana Biotech

5 Things You’ll Want to Know From the World’s Biggest Marijuana Biotech

Anticipation is building for GW Pharmaceuticals (NASDAQ:GWPH) as the biotech prepares to hopefully launch its first product in the U.S. in 2018.

FDA

FDA Warns Companies Marketing Unproven Products, Derived From Marijuana, That Claim to Treat or Cure Cancer

WASHINGTON, Nov. 1, 2017 /Weed Wire/ — As part of the U.S. Food and Drug Administration’s ongoing efforts to protect consumers from health fraud, the agency today issued warning letters to four companies illegally selling products online that claim to prevent, diagnose, treat, or cure cancer without evidence to support these outcomes.

Better Know a Marijuana Stock: Arena Pharmaceuticals

Better Know a Marijuana Stock: Arena Pharmaceuticals

Unlike GW Pharmaceuticals and Zynerba Pharmaceuticals, which rely on cannabinoid-based medicines to fill out the entirety of their drug-development pipelines, Arena Pharmaceuticals is one of the drug developers that have some of their pipelines devoted to cannabinoid-type therapeutics or CB agonists and other portions devoted to non-cannabinoid medicines.

Billion Dollar Fund Manager Targets Cannabis

Billion Dollar Fund Manager Targets Cannabis

First Trust Portfolios filed an S-6 on May 3oth with the Securities and Exchange Commission for a Medical Cannabis Portfolio Series – FT 6766 that is seeking above average capital appreciation.

Federal Legislation: Cannabidiol Research Expansion Act Introduced

Federal Legislation: Cannabidiol Research Expansion Act Introduced

On May 25, 2017, Sens. Dianne Feinstein, D-Calif., and Chuck Grassley, R-Iowa, announced that they had introduced the Cannabidiol Research Expansion Act, a bill that would ask the Attorney General to reconsider whether cannabidiol should be scheduled under the Controlled Substances Act and expand research opportunities as a means of determining the medical efficacy of cannabidiol and marijuana in the treatment of serious medical conditions.

Patrick Kennedy's anti-marijuana crusade

Patrick Kennedy’s Anti-Marijuana Crusade

In an interview with Yahoo News and Finance Anchor Bianna Golodryga, former Rep. Patrick Kennedy, D-R.I. claims lobbyists for marijuana legalization are attempting to sell Americans on a “Trojan horse.” Should members of the legal marijuana industry be concerned about Kennedy’s argument gaining momentum?

MJIN_MAPS-Logo-Web

Statement on the Adequacy of Marijuana Provided by NIDA for Phase 2 Clinical Trials for PTSD in Veterans

PHOENIX, March 17, 2017 /Weed Wire/ — As of March 15, 2017, five participants have received marijuana (cannabis) provided by the National Institute on Drug Abuse (NIDA) in an ongoing Phase 2 clinical trial sponsored by the non-profit Multidisciplinary Association for Psychedelic Studies (MAPS) at the Scottsdale Research Institute (SRI) in Phoenix, Ariz. MAPS is committed to sponsoring rigorous clinical research to develop cannabis into a prescription medicine through the Food and Drug Administration (FDA).

Dad Says Doctor Stopped Seeing His Daughter Due to CBD Oil Use

Dad Says Doctor Stopped Seeing His Daughter Due to CBD Oil Use

A Duke doctor has refused to continue seeing a nine-year-old North Carolina girl because her family gives her cannabidiol oil to cope with a rare illnes. The nine-year-old, Mia Morley, has a medical condition called Lennox Gastaut Syndrome. Her father, Dylan Morley, said Dr. Muhammad Mikati’s decision was based upon the federal status of CBD oil, which is not FDA approved.

Science and Medicine of Cannabis: What Role Will FDA Play in Medical Cannabis?

Science and Medicine of Cannabis: What Role Will FDA Play in MMJ?

Stephen Goldner, Senior Forensic Toxicologist at Quantum 9, learned early on how to work with the FDA, having developed the FDA-approved liquid dose form of methadone with his mentor John Broich. Hear Goldner discuss what role the FDA would likely play in life after medical cannabis legalization.

Can This Marijuana Stock Add Some Green to Your Portfolio?

Can This Marijuana Stock Add Some Green to Your Portfolio?

Investors in cannabis companies had an eventful 2016 with the approval of recreational marijuana usage in the states of California, Massachusetts, Maine, and Nevada providing a boost to all sorts of marijuana stocks. Of particular note, shares of Corbus Pharmaceuticals (NASDAQ: CRBP) posted a whopping 600% gain in 2016 following positive phase 2 data.

Science and Medicine of Cannabis: Coping With PTSD

Science and Medicine of Cannabis: Coping With PTSD

Sue Sisley, M.D., is leading the way in studying medical marijuana and post-traumatic stress disorder. In her talk, “Coping With PTSD,” hear Sisley discuss the first clinical trial to study the effects of medical marijuana in the treatment of post-traumatic stress disorder in military veterans.

GWPH Phase 3 Results

GW Pharmaceuticals Achieves Positive Results in Phase 2 Proof of Concept Study in Glioma

LONDON, Feb. 7, 2017 /Weed Wire/ — GW Pharmaceuticals plc (Nasdaq:GWPH) (“GW,” “the Company” or “the Group”), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform, today announced positive top-line results from an exploratory Phase 2 placebo-controlled clinical study.

Edibles Entrepreneurs in Oregon: Is the Surface Smooth and Easily Cleanable?

Edibles Entrepreneurs in Oregon: Smooth and Easily Cleanable Surfaces

While non-food-contact surfaces are critical to the form and function of a facility for edibles, food-contact surfaces are at the frontline of food safety. Equipment purchases have to ensure hygienic design and permit efficient disassembly for cleaning, scrubbing, inspecting and sanitizing.

SeeThruEquity RSHO Raúl Elizalde

Medical Marijuana, Inc. Subsidiary HempMeds Mexico® Receives COFEPRIS Permission for Flagship Product RSHO-X™ Usage for Cancer Patient

SAN DIEGO, Jan. 24, 2017/Weed Wire/ — Medical Marijuana, Inc. (OTC: MJNA) announced today that its subsidiary HempMeds Mexico® has received permission from Mexico’s health authority COFEPRIS to import their flagship product Real Scientific Hemp Oil-X™ (RSHO-X™) to treat a patient for their pain associated with cancer treatments and for their general well-being.

SeeThruEquity RSHO Raúl Elizalde

Medical Marijuana, Inc.’s Investment Axim(R) Biotech Files IP Application on Proprietary Method to Extract High-Purity THC

SAN DIEGO, Nov. 29, 2016 /Weed Wire/ — Medical Marijuana, Inc. (OTC PINK: MJNA), the first-ever publicly traded cannabis company in the United States, announced today that its major investment company AXIM® Biotechnologies, Inc. (AXIM® Biotech) (OTC PINK: AXIM) has filed an IP application with the World Intellectual Property Organization.

Edibles Entrepreneurs in Oregon: Invest in Food Safety Details

Edibles Entrepreneurs in Oregon: Invest in Food Safety Details

The Oregon Liquor Control Commission announced via email on Nov. 17 that it’s anticipating an influx of applications from prospective recreational marijuana businesses. If you hope to become a licensed recreational processor and want to avoid delays in having your application processed, compliance is critical.

Dive into the Science and Medicine of Cannabis

Dive into the Science and Medicine of Cannabis

Cannabinoids – what are they? How do they affect the human body? Are they really medicinal? On Nov. 16, 2016, Marijuana Investor Summit is bringing the Science and Medicine of Cannabis to the Palms Casino Resort in Las Vegas, Nevada, to answer these questions and more.

GWPH Phase 3 Results

GW Pharmaceuticals Announces New Planned Epidiolex (Cannabidiol or CBD) Development Program in Infantile Spasms (IS)

LONDON, June 21, 2016 /Weed Wire/ — GW Pharmaceuticals plc (Nasdaq: GWPH) (AIM: GWP) (“GW” or “the Company”) today announced that the Company has selected infantile spasms (IS) as the fourth target indication for its Epidiolex orphan pediatric epilepsy development program.

Progressive Edibles Executives: Keep Up with the Feds

Progressive Edibles Executives: Keep Up with the Feds

While the demand for edibles continues to rise, so too do the expectations for producers to follow good manufacturing practices and food safety plans consistent with federal requirements.

PTSD

DEA Approves Study of Smoked Marijuana For Treatment of PTSD

The U.S. Drug Enforcement Agency has given the green light to a clinical study of smoked marijuana’s effectiveness for treating Post Traumatic Stress Disorder in veterans, according to the Multidisciplinary Association for Psychedelic Studies. Seventy-six U.S. veterans will participate in the study.

Goldner

Life After Legalization: Stephen Goldner Leads the Way to FDA

When FDA barriers change, regulations deal fortune to some and hardship to others. On March 4, 2016, at the California Cannabis Business Expo in San Francisco, Stephen Goldner, Senior Forensic Toxicologist at Quantum 9, a cannabis consulting and technology firm, addressed the U.S. Food and Drug Administration’s role in regulating the cannabis industry in life after legalization.

Goldner

36 Days Until Stephen Goldner Explores Life After Legalization

Stephen Goldner, a forensic toxicologist at Quantum 9, a cannabis consulting and technology firm, will be discussing life after legalization at the California Cannabis Business Expo in San Francisco this March.

Clinton

Political Analysis: Clinton’s Switch on Marijuana Classification

Three days after presidential candidate and Vermont Sen. Bernie Sanders introduced the “Ending Federal Marijuana Prohibition Act” of 2015,” the grand dame of Democratic presidential politics finally changed her position on one of the most pressing political issues in America.

CLS Labeling Practices

The Future of Labeling in the Legal Cannabis Industry

With legalization happening on a state-by-stay basis and no overarching regulatory agency to devise and implement national standards for labeling, the torch has to be picked up by manufacturers.


Page 1 of 212
Top